Thym-uvocal

Thym-Uvocal contains protein-free dry substances from calf thymus extract; these are a standardized combination of thymus peptides, which may replace the decrease of thymic secretion associated with increasing age. The thymus gland undergoes an agerelated decrease in production of its various peptides. As thymus factors have been correlated with the strength of the immune system, Thym-Uvocal may help to boost the immune system. It appears to have a favorable action on the T-4/T-8 cell ratio, and thus a stimulating and modulating action on the cellular immune system. Thym-uvocal increases levels of antibodies and phagocytosis, increases interleukin-1 production, and activates macrophages and enhances their tumor cell destruction action.

Thym-Uvocal’s anti-aging benefits may include improved strength of the immune system, an increase in the thymic peptide blood count, prevention and treatment of infection, treatment of cancer, treatment of rheumatic disease, treatment of dermatology disorders such as neurodermatitis, aphthosis and psoriasis, treatment of allergic reaction and states of exhaustion, and management of AIDS.

The elderly are the most important target group for the administration of Thym-Uvocal and Thym-Uvocal’s main indications are diseases of old age.

Thym-Uvocal is available in 2ml ampules, topical cream, and 240mg tablets. Mulli of Germany manufactures it.

MAXIMUM SAFE LEVEL: Not established

There is a possibility of allergic minor reactions. Thym-Uvocal should not be administered to patients with thymic hyperfunction, such as myasthenia gravis, thymic tumors, and hypothyroidism.